ArticleJMIR research protocols2017

Assessing the Efficacy and Safety of an 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitor (AZD4017) in the Idiopathic Intracranial Hypertension Drug Trial, IIH:DT: Clinical Methods and Design for a Phase II Randomized Controlled Trial.

Keira Annie Markey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.